文章引用说明 更多>> (返回到该文章)

A. Freedman. Follicular lymphoma: 2011 update on diagnosis and management. American Journal of Hematology, 2011, 86(9): 768-775.

被以下文章引用:

  • 标题: CD10–MUM1+滤泡性淋巴瘤一例及文献学习CD10–MUM1+Follicular Lymphoma: A Case Report and Review of the Literature

    作者: 刘一雄, 郭英

    关键字: 滤泡性淋巴瘤, 免疫表型, CD10, MUM1, 亚型Follicular Lymphoma; Immnophenotype; CD10; MUM1; Subtype

    期刊名称: 《Medical Diagnosis》, Vol.2 No.3, 2012-09-28

    摘要: 目的:我院会诊一例外院无明确诊断、外周淋巴结肿大的老年患者,为明确诊断特做形态学、免疫组化及分子遗传学检测。方法:常规对福尔马林固定、石蜡包埋的淋巴结组织切片,做HE、免疫组化染色及荧光原位杂交实验。结果:免疫组化结果:瘤细胞CD20(+)、PAX-5(+)、BCL-2(+)、Mum1(+)、Bcl-6弱(+)、CD10(–)、CD23(+)、CD21(+)、CD43(–)、CyclinD1(–),Ki67增殖指数约50%。原位荧光杂交结果:IgH/BCL2易位(+),BCL6易位(–)。结论:本文介绍的滤泡性淋巴瘤病例符合较为少见的MUM1(+) CD10(–)滤泡性淋巴瘤亚型(80%)伴有弥漫性大B细胞淋巴瘤区域(20%),分级为3级b,据报道其预后较差,应当视作侵袭性淋巴瘤治疗。 Objective: In order to make definate diagnosis to an old patient with multiple lymph-node enlargement in the area of groin and submaxilla we made morphology and molecularbiology study. Methods: We carried out slice cut-ting from formalin fixed paraffin embedded tissue, then make HE and immunostaining. After that Fluorescence in situ hybridization (FISH) was performed to detect genetic abnormalities. Results: Immunostaining: CD20(+), PAX-5(+), BCL-2(+), Mum1(+), Bcl-6 weak(+), CD10(–), CD23(+), CD21(+), CD43(–), CyclinD1(–), Ki67 index was about 50%. FISH: IgH/BCL2 translocation (+), BCL6 translocation (–). Conclusion: The case we are intruducing here belongs to the rare subtype of follicular lymphoma which chracterized by MUM1(+) CD10(–) immunostaining marker. The pa-thology diagnosis is follicular lymphoma (MUM1(+) CD10(–)) (80%) with diffuse area(20%), degree: 3b. The progno-sis of this kind of follicular lymphoma is not good and should be treated as aggressive B cell lymphoma.

在线客服:
对外合作:
联系方式:400-6379-560
投诉建议:feedback@hanspub.org
客服号

人工客服,优惠资讯,稿件咨询
公众号

科技前沿与学术知识分享